This article was originally published in The Rose Sheet
Robert Bertolini tapped exec VP and CFO, effective Nov. 17, company announces. Reporting to CEO Fred Hassan, Bertolini will be responsible for building a global finance team dedicated to transforming Schering into a successful international competitor, firm says. Exec, who previously served as a lead partner in PricewaterhouseCoopers' Global Pharmaceutical Industry Group, succeeds Jack Wyszomierski, who is leaving the firm to pursue other interests. Bertolini's appointment is "an important step" in implementing Schering's turnaround plan, according to the company (1"The Rose Sheet" July 14, 2003, p. 9)...
You may also be interested in...
Schering-Plough appointed former American Home Products Senior VP Stanley Barshay as chairman of its Consumer Health Care division effective July 7
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.